Improvement of liver function parameters in advanced HCV-associated liver cirrhosis by IFN-free antiviral therapies-Reference-Cited by-同舟云学术

Improvement of liver function parameters in advanced HCV-associated liver cirrhosis by IFN-free antiviral therapies

Published:2015-08-06 Issue:7 Volume:42 Page:889-901
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Deterding K.¹,Höner zu Siederdissen C.¹,Port K.¹,Solbach P.¹,Sollik L.¹,Kirschner J.¹,Mix C.¹,Cornberg J.¹,Worzala D.¹,Mix H.¹,Manns M. P.¹,Cornberg M.¹,Wedemeyer H.¹

Affiliation:

1. Department of Gastroenterology, Hepatology and Endocrinology; Hannover Medical School; Hannover Germany

Funder

Integrated Research and Treatment Center Transplantation

Hannover Medical School

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/apt.13343/fullpdf

Reference39 articles.

1. Global epidemiology and genotype distribution of the hepatitis C virus infection;Gower;J Hepatol,2014

2. Treating viral hepatitis C: efficacy, side effects, and complications;Manns;Gut,2006

3. Sofosbuvir for previously untreated chronic hepatitis C infection;Lawitz;N Engl J Med,2013

4. Sofosbuvir for hepatitis C genotype 2 or 3 in patients without treatment options;Jacobson;N Engl J Med,2013

5. Sofosbuvir and ribavirin in HCV genotypes 2 and 3;Zeuzem;N Engl J Med,2014

Cited by 106 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Direct-acting antivirals failed to reduce the incidence of hepatocellular carcinoma occurrence in hepatitis C virus associated cirrhosis: A real-world study;World Journal of Hepatology;2024-01-27

2. Hepatitis C Virus Infection in the Elderly in the Era of Direct-Acting Antivirals: Evidence from Clinical Trials and Real Life;Tropical Medicine and Infectious Disease;2023-11-18

3. The effect of direct-acting antivirals (DAA) on confirmed noninvasive fibrous parameters in chronic hepatitis C patients;Anatolian Current Medical Journal;2023-10-27

4. Effectiveness and safety of generic and brand direct acting antivirals for treatment of chronic hepatitis C;World Journal of Clinical Cases;2022-12-06

5. Direct-Acting Antiviral Therapy for Hepatitis C Virus in Patients with BCLC Stage B/C Hepatocellular Carcinoma;Viruses;2022-10-22